Ocugen, Inc

+$0.02 (+0.83%) As of 3:31 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ocugen, Inc and other ETFs, options, and stocks.

About OCGN

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN.

CEO
Shankar Musunuri
Employees
56
Headquarters
Malvern, Pennsylvania
Founded
2013

OCGN Key Statistics

Market cap
526.22M
Price-Earnings ratio
—
Dividend yield
—
Average volume
7.01M
High today
$2.52
Low today
$2.33
Open price
$2.39
Volume
1.58M
52 Week high
$17.65
52 Week low
$1.67

OCGN Earnings

-$0.13
-$0.08
-$0.03
$0.02
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 5, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure